Jane Pillow
Research Theme Head, Early Environment; Team Lead, Chronobiology
BMedSci (Dist) MBBS, PhD (Dist) FRACP
jane.pillow@thekids.org.au
Professor Jane Pillow is an academic neonatologist with an active clinical and preclinical research program, with a longstanding focus on improving the cardiorespiratory outcome of preterm infants. She is the CIA and Co-Director of the NHMRC Centre of Research Excellence to improve the immediate and long-term outcomes of preterm infants.
She is the Founding Director of the UWA Preclinical Intensive Care Research Unit (PICRU). Her clinical research program has contributed to the detailed understanding and development of sophisticated and non-invasive methods of assessing lung function at the bedside of newborn infants, and improving non-invasive treatment including nebulised surfactant.
She is internationally renowned for her expertise in the development and teaching of lung protective respiratory support to limit injury to fragile lungs of premature babies.
In recent years, her research program has focused on systemic modifiers of lung development including interventions in relation to infection, inflammation and circadian rhythm as a means to improving not just cardiorespiratory but overall outcomes for premature and very premature infants.
Projects
The development and refinement of a sensitive bedside test to continually measure the severity of BPD and lung development in preterm infants
Characterising the development of molecular and hormonal circadian rhythm development in preterm infants
Published research
Respiratory and chest wall mechanics in very preterm infants
Data on static compliance of the chest wall (Ccw) in preterm infants are scarce. We characterized the static compliance of the lung and Ccw to determine their relative contribution to static compliance of the respiratory system in very preterm infants at 36 wk postmenstrual age. We also aimed to investigate how these compliances were influenced by the presence of bronchopulmonary dysplasia and impacted breathing variables.
Antenatal creatine supplementation reduces persistent fetal lung inflammation and oxidative stress in an ovine model of chorioamnionitis
Chorioamnionitis is a common antecedent of preterm birth and induces inflammation and oxidative stress in the fetal lungs. Reducing inflammation and oxidative stress in the fetal lungs may improve respiratory outcomes in preterm infants. Creatine is an organic acid with known anti-inflammatory and antioxidant properties.
Vitamin A and bronchopulmonary dysplasia: the next steps
Preterm infants are often vitamin A deficient, and vitamin A has functions that could mitigate the processes that lead to bronchopulmonary dysplasia. Therefore, supplementation of preterm infants with vitamin A to reduce the risk of bronchopulmonary dysplasia makes inherent sense.
Neonatal high frequency ventilation: Current trends and future directions
High frequency ventilation (HFV) in neonates has been in use for over forty years. Some early HFV ventilators are no longer available, but high frequency oscillatory ventilation (HFOV) and jet ventilators (HFJV) continue to be commonly employed. Advanced HFOV models available outside of the United States are much quieter and easier to use, and are available as options on many conventional ventilators, providing important improvements such as tidal volume measurement and targeting.
Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Normal in utero lung development and growth rely upon the expansion of airspaces and the controlled efflux of lung liquid into the amniotic space. Infants with congenital diaphragmatic hernia (CDH) also have lung hypoplasia due to occupation of the chest cavity by the stomach and bowel and, in the most severe cases, the liver. Balloon tracheal occlusion reduces the severity of lung hypoplasia in fetuses with CDH but increases the risk of premature birth.
A systematic review of chronobiology for neonatal care units: What we know and what we should consider
A Cochrane 2016 review indicated cycled light might benefit neonatal health in hospital. We systematically reviewed chronobiological factors for neonatal health in hospital units, identifying 56 relevant studies on light-dark cycles, feeding, noise, massage therapy, rooming-in, incubators vs. cribs, neonatal units vs. homes, and time-of-day of birth. Empirical evidence for benefits from chronobiology is weaker than expected, including light.
Surfactant delivery by aerosol inhalation – past, present, and future
Surfactant replacement therapy by nebulization to spontaneously breathing patients has been regarded as the Holy Grail since surfactant deficiency was first identified as the cause for neonatal respiratory distress syndrome. It avoids neonatal endotracheal intubation, a procedure that is often difficult and occasionally harmful.
Towards a harmonized bronchopulmonary dysplasia definition: a study protocol for an international Delphi procedure
Bronchopulmonary dysplasia (BPD) remains the most common complication of preterm birth with lifelong consequences. Multiple BPD definitions are currently used in daily practice. Uniformity in defining BPD is important for clinical care, research and benchmarking. The aim of this Delphi procedure is to determine what clinicians and researchers consider the key features for defining BPD.
Neonatal high-frequency oscillatory ventilation: where are we now?
High-frequency oscillatory ventilation (HFOV) is an established mode of respiratory support in the neonatal intensive care unit. Large clinical trial data is based on first intention use in preterm infants with acute respiratory distress syndrome. Clinical practice has evolved from this narrow population. HFOV is most often reserved for term and preterm infants with severe, and often complex, respiratory failure not responding to conventional modalities of respiratory support.
Elevated leukotriene B4 and 8-isoprostane in exhaled breath condensate from preterm-born infants
Inflammation and oxidative stress play a key role in the development of bronchopulmonary dysplasia (BPD), possibly contributing to persistent respiratory morbidity after preterm birth. We aimed to assess if inflammatory markers were elevated in exhaled breath condensate (EBC) of infants born very prematurely (< 32 weeks gestation) at 12-16 corrected months of age, and if increased levels were associated with BPD diagnosis and respiratory morbidity.
Unstable SpO2 in preterm infants: The key role of reduced ventilation to perfusion ratio
Instability of peripheral oxyhemoglobin saturation (SpO2) in preterm infants is correlated with late disability and is poorly understood. We hypothesised that a reduced ventilation to perfusion ratio (VA/Q) is the key predisposing factor for SpO2 instability.
Ventilatory response and stability of oxygen saturation during a hypoxic challenge in very preterm infants
Preterm infants have immature control of breathing and impaired pulmonary gas exchange. We hypothesized that infants with bronchopulmonary dysplasia (BPD) have a blunted ventilatory response and peripheral oxygen saturation (SpO2 ) instability during a hypoxic challenge.
The ventilatory response to hypoxia is blunted in some preterm infants during the second year of life
Preterm birth and subsequent neonatal ventilatory treatment disrupts development of the hypoxic ventilatory response (HVR). An attenuated HVR has been identified in preterm neonates, however it is unknown whether the attenuation persists into the second year of life.
Living with lung disease: experimental models to assess the long-term effects of prematurity
Laboratory models provide an important tool in helping to understand the cellular and molecular drivers of respiratory disease. Many animal models exist that model the neonatal outcomes of preterm birth.
Airway smooth muscle thickness and contraction are enhanced by intra-amniotic lipopolysaccharide in an ovine model of premature birth
Abnormalities of the airway smooth muscle (ASM) layer in asthma may develop before birth. We hypothesize that antenatal inflammation causes physiological abnormalities of the ASM that predisposes asthma. This study determined the short-term effects of antenatal inflammation on the developing ASM.
Impact of fetal treatments for congenital diaphragmatic hernia on lung development
The extent of lung hypoplasia impacts the survival and severity of morbidities associated with congenital diaphragmatic hernia.
Epidemiology of Neonatal Acute Respiratory Distress Syndrome: Prospective, Multicenter, International Cohort Study
Age-specific definitions for acute respiratory distress syndrome (ARDS) are available, including a specific definition for neonates (the "Montreux definition"). The epidemiology of neonatal ARDS is unknown. The objective of this study was to describe the epidemiology, clinical course, treatment, and outcomes of neonatal ARDS.
Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial
The importance of lung recruitment before surfactant administration has been shown in animal studies. Well designed trials in preterm infants are absent. We aimed to examine whether the application of a recruitment manoeuvre just before surfactant administration, followed by rapid extubation (intubate-recruit-surfactant-extubate [IN-REC-SUR-E]), decreased the need for mechanical ventilation during the first 72 h of life compared with no recruitment manoeuvre (ie, intubate-surfactant-extubate [IN-SUR-E]).
Simplified bedside assessment of pulmonary gas exchange in very preterm infants at 36 weeks' postmenstrual age
We aimed to develop and validate a prediction table for a simplified measure of rightward shift of the fetal oxyhaemoglobin saturation (SpO2) versus inspired oxygen pressure (P IO2) curve as an objective marker of lung disease severity in very preterm infants, independent of unit altitude or oxygen prescribing policies.
Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial
Evidence suggests that intramuscular vitamin A reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants. Our objective was to compare enteral water-soluble vitamin A with placebo supplementation to reduce the severity of BPD in extremely preterm infants.
Vitamin A supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: A systematic review and meta-Analysis of randomized trials
A previous systematic review showed that intramuscular vitamin A supplementation reduced the risk of bronchopulmonary dysplasia (BPD) in very-low-birth-weight (VLBW) infants. However, more recent studies have questioned this finding.
Effect of Enteral Vitamin A on Fecal Calprotectin in Extremely Preterm Infants: A Nested Prospective Observational Study
Vitamin A has anti-inflammatory and immune-modulating properties. We aimed to assess whether enteral water-soluble vitamin A supplementation in extremely preterm infants decreases fecal calprotectin, a marker of intestinal inflammation.
Pulmonary Gas Exchange Improves over the First Year in Preterm Infants with and without Bronchopulmonary Dysplasia
Right shift of the peripheral oxyhaemoglobin saturation (SpO2) versus inspired oxygen pressure (PIO2) curve is a sensitive marker of pulmonary gas exchange. The aim of this study was to assess the impact of prematurity and bronchopulmonary dysplasia (BPD) on gas exchange and right-to-left shunt in the neonatal period, and its evolution over the first year of life.
Education and Qualifications
Professor Pillow studied Medicine at the University of Queensland, graduating in 1987. During this time she also completed a Bachelor of Medical Science (awarded with Distinction) at the Royal Children’s Hospital in Melbourne. She completed her Internship in North Queensland and subsequently trained in Paediatrics and Neonatal/Perinatal Medicine at the Royal Children’s Hospital and Monash Medical Centre in Melbourne. She was awarded an FRACP in 1996 and Neonatal Subspecialist qualification in 1997. She completed her PhD (awarded with Distinction), in 2000 on Optimising High Frequency Oscillatory Ventilation. She undertook an NHMRC Neil Hamilton Fairley Postdoctoral Scholarship at the Institute for Child Health in London (UCL) from 2001-2003, before returning to complete the last 2 years of her postdoctoral Fellowship in Perth in 2004. She has been successful with support from Research Fellowships throughout her career including an NHMRC Career Development Fellowship, Sylvia and Charles Viertel Senior Medical Research Fellowship and an NHMRC Senior Research Fellowship. In addition to her active research career, she worked as a Consultant Neonatologist from 1997-2015 at PMH, KEMH and UCLH.
Awards and Honours
-
2015 NHMRC 10 of the best research projects
-
2015 UWA Vice Chancellor’s mid-career research prize
-
2015 NHMRC Senior Research Fellowship
-
2013 Richard D Rowe Clinical Research Award
-
2012 UWA Safety-Net Award
-
2011 Bengt Robertson Lecturer, European Society of Paediatric Research, Newcastle UK
-
2007 Sylvia & Charles Viertel Senior Medical Research Fellowship (5 year)
-
2006 NHMRC Clinical Career Development Award 2006-2010)
-
2004 The CASS Foundation – Travelling Fellowship for attendance at ATS & SPR, May 2005
-
2000 Neil Hamilton Fairley Postdoctoral Training Fellowship
-
1998 Allen & Hanbury’s Travel Grant (Thoracic Society Aust & NZ, WA Branch)
-
1998 Glaxo-Wellcome Neonatal Travelling Scholarship Australian College of Paediatrics
-
1998 NH&MRC Postgraduate Medical Research Scholarship
-
1997 Athelstan and Amy Saw Medical Research Fellowship, UWA
-
1997 Paediatric Research Award, Monash Medical Centre
-
1994 Eric Burnard Travelling Fellowship (Aust. College of Paediatrics)
-
1994 SW Shield Part-Time Research Fellowship (Royal Aust. College of Physicians)1985 NHMRC Medical Undergraduate Scholarship (B. Med. Sci., at RCH, Melbourne)
Key Collaborators
- Politecnico di Milano, Italy (Prof Raffaele Dellaca)
- Maastricht University, Netherlands (Associate Professor Tim Wolfs)
- Hudson Institute of Medical Research, Monash Children’s Hospital, Melbourne (Associate Professor Tim Moss)
- Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne (Prof Rod Hunt)
- Murdoch University, Perth (Dr Andrew Currie)
- University of Western Australia (Dr Dominique Blache, Gavin Pinniger, Peter Mark, Anthony Bakker)
External Committees
- Academic Representative, ANZNN Executive (2015-)
- Chair- ANZNN working Group on Bronchopulmonary Dysplasia (2019-)
- Chair, AF Pillow Applied Mathematics Trust